Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CEA-C004 | Human | ClinMax™Human Interleukin 8 (IL-8) Quantitative ELISA Kit | |||
CRS-A007 | Human | Human Interleukin-8(IL-8) ELISA Kit | |||
IL8-H82H3 | Human | Biotinylated Human IL-8 protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
IL8-C52H3 | Cynomolgus | Cynomolgus IL-8 / CXCL8 Protein, His Tag | ![]() |
||
IL8-H5258 | Human | Human IL-8 / CXCL8 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL8-H52H3 | Human | Human IL-8 / CXCL8 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human IL-8, Fc Tag (Cat. No. IL8-H5258) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Human IL-8 Antibody, Human IgG1 with a linear range of 0.2-4 ng/mL (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Mouse monoclonal antibody against human interleukin-8 cream | Approved | Dalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd | 恩博克 | Mainland China | Eczema; Psoriasis | Dalian Asia Space Pharmaceutical Co Ltd | 2001-04-10 | Psoriasis; Eczema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
Cis-urocanic acid | Cis-UCA; UCA-001; UCA-002 | Phase 2 Clinical | Herantis Pharma | Dry Eye Syndromes; Urinary Bladder Neoplasms; Xerophthalmia; Dermatitis, Atopic | Details |
HL-2351 | GX-P4; HL-2351; rhIL-1Ra-hyFc | Phase 1 Clinical | Genexine Inc | Arthritis, Rheumatoid; Cryopyrin-Associated Periodic Syndromes | Details |
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Tissue Adhesions; Post-surgical adhesions; Cicatrix | Details |
HuMax-IL8 | MDX-018; BMS-986253 | Phase 2 Clinical | Medarex, Genmab, Bristol-Myers Squibb Company | Liver Neoplasms; Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.